An aerosol challenge mouse model for Moraxella catarrhalis

Vaccine

Volumn 18, Issue 9-10, 1999, Pages 799-804

  Hu, Wei Gang ^a   Chen, Jing ^a   Collins, Frank M ^b   Gu, Xin Xing ^a  

^a NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS   (United States)

^b CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Aerosol challenge; Animal model; M. catarrhalis

Indexed keywords

RABBIT ANTISERUM; VACCINE;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HISTOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LUNG CLEARANCE; LUNG PARENCHYMA; MORAXELLA CATARRHALIS; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL;

AEROSOLS; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; IMMUNE SERA; IMMUNIZATION, PASSIVE; LUNG; MICE; MICE, INBRED BALB C; MORAXELLA (BRANHAMELLA) CATARRHALIS; NEISSERIACEAE INFECTIONS; RABBITS;

EID: 0032747390     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00335-7     Document Type: Article

References (23)

1. Catlin B.W. Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin. Microbiol. Rev. 3:1990;293-320.
2. Enright M.C., McKenzie H. Moraxella (Branhamella) catarrhalis clinical and molecular aspects of a rediscovered pathogen. J. Med. Microbiol. 46:1997;360-371.
3. Murphy T.F. Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol. Rev. 60:1996;267-279.
4. Bluestone C.D. Otitis media and sinusitis in children: role of Branhamella catarrhalis. Drugs. 31:(Suppl. 3):1986;132-141.
5. Christensen J.J. Moraxella (Branhamella) catarrhalis: clinical, microbiological and immunological features in lower respiratory tract infections. APMIS. 88:(Suppl.):1999;1-36.
6. Helminen M.E., Maciver I., Latimer J.L., Cope L.D., McCracken G.H. Jr., Hansen E.J. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect. Immun. 61:1993;2003-2010.
7. Chen D., McMichael J.C., VanDerMeid K.R., Hahn D., Mininni T., Cowell J., Eldridge J. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect. Immun. 64:1996;1900-1905.
8. Gu X.-X., Chen J., Barenkamp S.J., Robbins J.B., Tsai C.M., Lim D.J., Battey J. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis. Infect. Immun. 66:1998;1891-1897.
9. Myers L.E., Yang Y.P., Du R.P., Wang Q., Harkness R.E., Schryvers A.B., Klein M.H., Loosmore S.M. The transferrin binding protein B of Moraxella catarrhalis elicits bactericidal antibodies and is a potential vaccine antigen. Infect. Immun. 66:1998;4183-4192.
10. Murphy T.F., Kyd J.M., John A., Kirkham C., Cripps A.W. Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model. J. Infect. Dis. 178:1998;1667-1675.
11. Ruedl C., Fruhwirth M., Wick G., Wolf H. Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens. Clin. Diagn. Lab. Immunol. 1:1994;150-154.
12. Westman E.B., Hermansson A., Prellner K., Melhus A., Hellstrom S. Moraxella catarrhalis-induced purulent otitis media in the rat middle ear. Mogi G., Honig I., Ishii T., Takasaka T. Proceedings of the Second Extraordinary International Symposium on Recent Advances in Otitis Media. 1994;193-195 Kugler Publications, Amsterdam.
13. Unhanand M., Maciver I., Ramilo O., Arencibia-Mireles O., Argyle J.C., McCracken G.H. Jr., Hansen E.J. Pulmonary clearance of Moraxella catarrhalis in an animal mode. J. Infect. Dis. 165:1992;644-650.
14. Harkness R.E., Guimond M.-J., Mcbey B.-A., Klein M.H., Percy D.H., Croy B.A. Branhamella catarrhalis pathogenesis in SCID and SCID/beige mice. APMIS. 101:1993;805-810.
15. Doyle W.J. Animal models of otitis media: other pathogens. Pediatr. Infect. Dis. J. 8:1989;S45-S47.
16. Chung M.H., Enrique R., Lim D.J., De Maria T.F. Moraxella (Branhamella) catarrhalis-induced experimental otitis media in the chinchilla. Acta. Otolaryngol. (Stockholm). 114:1994;415-422.
17. Bakaletz L.O., Murwin D.M., Billy J.M. Adenovirus serotype 1 does not act synergistically with Moraxella (Branhamella) catarrhalis to induce otitis media in the chinchilla. Infect. Immun. 63:1995;4188-4190.
18. Henriksen S.D. Moraxella, Neisseria, Branhamella and Acinetobacter. Annu. Rev. Microbiol. 30:1976;63-83.
19. Orme I.M., Collins F.M. Mouse model of tuberculosis. Bloom B.R. Tuberculosis: pathogenesis, protection and control. 1994;113-134 ASM Press, Washington, DC.
20. Ribi E., Granger D.L., Milner K.C., Yamamoto K., Strain S.M., Parker R., Smith R.W., Brehmer W., Azuma I. Induction of resistance to tuberculosis in mice with defined components of mycobacteria and with some unrelated materials. Immunology. 46:1982;297-305.
21. Shahin R.D., Cowell J.L. Mouse respiratory infection models for pertussis. Methods Enzymol. 25:1994;47-58.
22. McGehee J.L., Radolf J.D., Toews G.B., Hansen E.J. Effect of primary immunization on pulmonary clearance of nontypable Haemophilus influenzae. Am. J. Respir. Cell. Mol. Biol. 1:1989;201-210.
23. Foxwell A.R., Kyd J.M., Cripps A.W. Characteristics of the immunological response in the clearance of nontypeable Haemophilus influenzae from the lung. Immunol. Cell. Biol. 76:1998;323-331.